English Deutsch 中文
XinTech
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
XinTech
Menu Deutsch 中文

Beijing SL Pharma Forms JV with Canadian Startup

Aug. 15, 2011

Beijing SL Pharmaceutical announced on Aug. 16, 2011 that it will invest $20 million in a JV with Canadian PnuVax, which will be located in Canada. Beijing SL Pharma will own 85% of the JV while PnuVax will own the remaining share by providing its vaccine and antibody technologies and know how.
The JV’s initial focus will be on 23-valent pneumococcal polysaccharide vaccines (PPSVs) that are intended for the China market.